The emerging class of GLP-1 receptor agonist and GIP dual medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, represent promising advances in the management . Despite all https://copper-peptides-for-skin716297.total-blog.com/retatrutide-a-detailed-look-69402398